Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is June - May.

Year Ending	Current	May 28, 2023	May 29, 2022	May 30, 2021	May 31, 2020	May 26, 2019
Market Capitalization	150	241	291	351	311	275
Market Cap Growth	-17.27%	-17.27%	-17.12%	12.76%	13.27%	-29.02%
Enterprise Value	243	334	440	566	532	426
PE Ratio	-	-2.42	-2.49	-10.87	-8.15	668.86
PS Ratio	1.45	2.33	2.62	3.48	1.95	0.49
PB Ratio	-56.91	-56.91	3.31	1.73	1.35	1.02
P/FCF Ratio	-6.18	-6.18	-5.66	84.38	-7.54	-9.66
P/OCF Ratio	-13.80	-13.80	-12.88	21.32	-18.27	17.16
EV/Sales Ratio	2.36	3.24	3.96	5.61	3.32	0.76
EV/EBITDA Ratio	-4.89	-4.89	-4.98	-57.48	-22.66	19.05
EV/EBIT Ratio	-4.10	-4.10	-4.14	-19.04	-12.57	59.56
EV/FCF Ratio	-8.59	-8.59	-8.57	135.98	-12.89	-14.99
Debt / Equity Ratio	-26.63	-26.63	1.71	1.06	0.96	0.56
Debt / EBITDA Ratio	-1.65	-1.65	-1.70	-21.93	-9.42	6.82
Debt / FCF Ratio	-2.89	-2.89	-2.92	51.88	-5.35	-5.36
Quick Ratio	1.22	1.22	0.22	0.42	0.47	0.52
Current Ratio	2.39	2.39	0.66	1.46	0.96	0.97
Asset Turnover	0.40	0.40	0.30	0.20	0.29	1.22
Interest Coverage	-4.62	-4.62	-6.84	-3.33	-9.11	1.37
Return on Equity (ROE)	-215.80%	-215.80%	-80.20%	-15.40%	-15.20%	0.20%
Return on Assets (ROA)	-38.40%	-38.40%	-31.80%	-6.40%	-7.00%	0.10%
Return on Capital (ROIC)	-20.11%	-20.11%	-4.95%	-2.11%	-5.72%	0.28%
Earnings Yield	-66.51%	-41.36%	-40.11%	-9.20%	-12.27%	0.15%
FCF Yield	-26.00%	-16.17%	-17.66%	1.19%	-13.26%	-10.35%
Buyback Yield / Dilution	-1.67%	-1.67%	-0.59%	-0.45%	-1.94%	-2.48%
Total Shareholder Return	-1.67%	-1.67%	-0.59%	-0.45%	-1.94%	-2.48%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).